Trans-4-hydroxy-2-hexenal, a product of n-3 fatty acid peroxidation: Make some room HNE...

Free Radical Biology and Medicine

Volumn 49, Issue 1, 2010, Pages 1-8

  Long, Eric K ^a   Picklo, Matthew J ^a,b,c  

^a Department of Pharmacology Physiology and Therapeutics ^*  (United States)

^b UNIVERSITY OF NORTH DAKOTA   (United States)

^c GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

4 hydroxy 2 hexenal; 4 hydroxy 2 nonenal; 4 oxo 2 hexenal; Aldehydes; Docosahexaenoic acid; Lipid peroxidation; Oxidative damage; Polyunsaturated fatty acid

Indexed keywords

2 HEXENAL; 4 HYDROXY 2 HEXENAL; 4 HYDROXYNONENAL; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; UNCLASSIFIED DRUG; 4-HYDROXY-2-HEXENAL; 4-OXO-(E)-2-HEXENAL; ALDEHYDE; FISH OIL;

ADDUCTION; BRAIN; CYTOTOXICITY; FATTY ACID METABOLISM; FATTY ACID OXIDATION; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN TARGETING; QUANTITATIVE STUDY; RETINA; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; APOPTOSIS; CHEMISTRY; DRUG DETOXIFICATION; HUMAN; METABOLISM;

ALDEHYDES; ANIMALS; APOPTOSIS; BRAIN; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FISH OILS; HUMANS; LIPID PEROXIDATION; METABOLIC DETOXICATION, PHASE I; OXIDATIVE STRESS; RETINA; SIGNAL TRANSDUCTION;

EID: 77953026426     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.03.015     Document Type: Review

References (114)

1. Tanito M., Elliott M.H., Kotake Y., Anderson R.E. Protein modifications by 4-hydroxynonenal and 4-hydroxyhexenal in light-exposed rat retina. Invest. Ophthalmol. Vis. Sci. 2005, 46:3859-3868.
2. Long E.K., Rosenberger T.A., Picklo M.J. Ethanol withdrawal increases glutathione adducts of 4-hydroxy-2-hexenal but not 4-hydroxyl-2-nonenal in the rat cerebral cortex. Free Radic. Biol. Med. 2010, 48:384-390.
3. Shibata N., Yamada S., Uchida K., Hirano A., Sakoda S., Fujimura H., Sasaki S., Iwata M., Toi S., Kawaguchi M., Yamamoto T., Kobayashi M. Accumulation of protein-bound 4-hydroxy-2-hexenal in spinal cords from patients with sporadic amyotrophic lateral sclerosis. Brain Res. 2004, 1019:170-177.
4. Poli G., Dianzani M.U., Cheeseman K.H., Slater T.F., Lang J., Esterbauer H. Separation and characterization of the aldehydic products of lipid peroxidation stimulated by carbon tetrachloride or adp-iron in isolated rat hepatocytes and rat liver microsomal suspensions. Biochem. J. 1985, 227:629-638.
5. Schneider C., Boeglin W.E., Yin H., Ste D.F., Hachey D.L., Porter N.A., Brash A.R. Synthesis of dihydroperoxides of linoleic and linolenic acids and studies on their transformation to 4-hydroperoxynonenal. Lipids 2005, 40:1155-1162.
6. Schneider C., Porter N.A., Brash A.R. Autoxidative transformation of chiral omega6 hydroxy linoleic and arachidonic acids to chiral 4-hydroxy-2e-nonenal. Chem. Res. Toxicol. 2004, 17:937-941.
7. Schneider C., Tallman K.A., Porter N.A., Brash A.R. Two distinct pathways of formation of 4-hydroxynonenal. Mechanisms of nonenzymatic transformation of the 9- and 13-hydroperoxides of linoleic acid to 4-hydroxyalkenals. J. Biol. Chem. 2001, 276:20831-20838.
8. Schneider C., Porter N.A., Brash A.R. Routes to 4-hydroxynonenal: Fundamental issues in the mechanisms of lipid peroxidation. J. Biol. Chem. 2008, 283:15539-15543.
9. VanRollins M., Murphy R.C. Autooxidation of docosahexaenoic acid: Analysis of ten isomers of hydroxydocosahexaenoate. J. Lipid Res. 1984, 25:507-517.
10. Kawai Y., Takeda S., Terao J. Lipidomic analysis for lipid peroxidation-derived aldehydes using gas chromatography-mass spectrometry. Chem. Res. Toxicol. 2007, 20:99-107.
11. Van Kuijk F.J., Holte L.L., Dratz E.A. 4-hydroxyhexenal: A lipid peroxidation product derived from oxidized docosahexaenoic acid. Biochim. Biophys. Acta 1990, 1043:116-118.
12. Beckman J.K., Howard M.J., Greene H.L. Identification of hydroxyalkenals formed from omega-3 fatty acids. Biochem. Biophys. Res. Commun. 1990, 169:75-80.
13. Long E.K., Smoliakova I., Honzatko A., Picklo M.J. Structural characterization of alpha, beta-unsaturated aldehydes by gc/ms is dependent upon ionization method. Lipids 2008, 43:765-774.
14. Long E.K., Murphy T.C., Leiphon L.J., Watt J., Morrow J.D., Milne G.L., Howard J.R., Picklo M.J. Trans-4-hydroxy-2-hexenal is a neurotoxic product of docosahexaenoic (22:6; n-3) acid oxidation. J. Neurochem. 2008, 105:714-724.
15. Lee S.H., Oe T., Blair I.A. Vitamin c-induced decomposition of lipid hydroperoxides to endogenous genotoxins. Science 2001, 292:2083-2086.
16. Lee S.H., Blair I.A. Characterization of 4-oxo-2-nonenal as a novel product of lipid peroxidation. Chem. Res. Toxicol. 2000, 13:698-702.
17. Griesser M., Boeglin W.E., Suzuki T., Schneider C. Convergence of the 5-lox and cox-2 pathways. Heme-catalyzed cleavage of the 5s-hete-derived di-endoperoxide into aldehyde fragments. J. Lipid Res. 2009, 50:2455-2462.
18. Zhu P., Jian W., Blair I.A. A 4-oxo-2(e)-nonenal-derived glutathione adduct from 15-lipoxygenase-1-mediated oxidation of cytosolic and esterified arachidonic acid. Free Radic. Biol. Med. 2009, 47:953-961.
19. Lang J., Celotto C., Esterbauer H. Quantitative determination of the lipid peroxidation product 4-hydroxynonenal by high-performance liquid chromatography. Anal. Biochem. 1985, 150:369-378.
20. Grune T., Kramer K., Hoppe P.P., Siems W. Enrichment of eggs with n-3 polyunsaturated fatty acids: Effects of vitamin e supplementation. Lipids 2001, 36:833-838.
21. van Kuijk F.J., Siakotos A.N., Fong L.G., Stephens R.J., Thomas D.W. Quantitative measurement of 4-hydroxyalkenals in oxidized low-density lipoprotein by gas chromatography-mass spectrometry. Anal. Biochem. 1995, 224:420-424.
22. Winter C.K., Segall H.J., Jones A.D. Distribution of trans-4-hydroxy-2-hexenal and tandem mass spectrometric detection of its urinary mercapturic acid in the rat. Drug Metab. Dispos. 1987, 15:608-612.
23. Segall H.J., Wilson D.W., Dallas J.L., Haddon W.F. Trans-4-hydroxy-2-hexenal: A reactive metabolite from the macrocyclic pyrrolizidine alkaloid senecionine. Science 1985, 229:472-475.
24. Alary J., Bravais F., Cravedi J.P., Debrauwer L., Rao D., Bories G. Mercapturic acid conjugates as urinary end metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in the rat. Chem. Res. Toxicol. 1995, 8:34-39.
25. Alary J., Debrauwer L., Fernandez Y., Paris A., Cravedi J.P., Dolo L., Rao D., Bories G. Identification of novel urinary metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in rats. Chem. Res. Toxicol. 1998, 11:1368-1376.
26. Laurent A., Perdu-Durand E., Alary J., Debrauwer L., Cravedi J.P. Metabolism of 4-hydroxynonenal, a cytotoxic product of lipid peroxidation, in rat precision-cut liver slices. Toxicol. Lett. 2000, 114:203-214.
27. Berhane K., Widersten M., Engstrom A., Kozarich J.W., Mannervik B. Detoxication of base propenals and other alpha, beta-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:1480-1484.
28. Hubatsch I., Ridderstrom M., Mannervik B. Human glutathione transferase a4-4: An alpha class enzyme with high catalytic efficiency in the conjugation of 4-hydroxynonenal and other genotoxic products of lipid peroxidation. Biochem. J. 1998, 330:175-179.
29. He Q., Khanna P., Srivastava S., van Kuijk F.J., Ansari N.H. Reduction of 4-hydroxynonenal and 4-hydroxyhexenal by retinal aldose reductase. Biochem. Biophys. Res. Commun. 1998, 247:719-722.
30. Guichardant M., Bacot S., Moliere P., Lagarde M. Hydroxy-alkenals from the peroxidation of n-3 and n-6 fatty acids and urinary metabolites. Prostaglandins Leukot. Essent. Fatty Acids 2006, 75:179-182.
31. Amunom I., Stephens L.J., Tamasi V., Cai J., Pierce W.M., Conklin D.J., Bhatnagar A., Srivastava S., Martin M.V., Guengerich F.P., Prough R.A. Cytochromes p450 catalyze oxidation of alpha, beta-unsaturated aldehydes. Arch. Biochem. Biophys. 2007, 464:187-196.
32. Murphy T.C., Amarnath V., Gibson K.M., Picklo M.J. Oxidation of 4-hydroxy-2-nonenal by succinic semialdehyde dehydrogenase (aldh5a). J. Neurochem. 2003, 86:298-305.
33. Brichac J., Ho K.K., Honzatko A., Wang R., Lu X., Weiner H., Picklo M.J. Enantioselective oxidation of trans-4-hydroxy-2-nonenal is aldehyde dehydrogenase isozyme and mg2+ dependent. Chem. Res. Toxicol. 2007, 20:887-895.
34. Lame M.W., Segall H.J. Metabolism of the pyrrolizidine alkaloid metabolite trans-4-hydroxy-2-hexenal by mouse liver aldehyde dehydrogenases. Toxicol. Appl. Pharmacol. 1986, 82:94-103.
35. Mally A., Amberg A., Hard G.C., Dekant W. Are 4-hydroxy-2(e)-nonenal derived mercapturic acids and (1)h nmr metabonomics potential biomarkers of chemically induced oxidative stress in the kidney?. Toxicology 2007, 230:244-255.
36. Kuiper H.C., Langsdorf B.L., Miranda C.L., Joss J., Jubert C., Mata J.E., Stevens J.F. Quantitation of mercapturic acid conjugates of 4-hydroxy-2-nonenal and 4-oxo-2-nonenal metabolites in a smoking cessation study. Free Radic. Biol. Med. 2010, 48:65-72.
37. Kuiper H.C., Miranda C.L., Sowell J.D., Stevens J.F. Mercapturic acid conjugates of 4-hydroxy-2-nonenal and 4-oxo-2-nonenal metabolites are in vivo markers of oxidative stress. J. Biol. Chem. 2008, 283:17131-17138.
38. Doorn J.A., Petersen D.R. Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal. Chem. Res. Toxicol. 2002, 15:1445-1450.
39. Doorn J.A., Petersen D.R. Covalent adduction of nucleophilic amino acids by 4-hydroxynonenal and 4-oxononenal. Chem. Biol. Interact. 2003, 143-144:93-100.
40. Esterbauer H., Schaur R., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde, and related aldehydes. Free Radic. Biol. Med. 1991, 11:81-128.
41. LoPachin R.M., Gavin T., Petersen D.R., Barber D.S. Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: Nucleophilic targets and adduct formation. Chem. Res. Toxicol. 2009, 22:1499-1508.
42. Bacot S., Bernoud-Hubac N., Baddas N., Chantegrel B., Deshayes C., Doutheau A., Lagarde M., Guichardant M. Covalent binding of hydroxy-alkenals 4-hdde, 4-hhe, and 4-hne to ethanolamine phospholipid subclasses. J. Lipid Res. 2003, 44:917-926.
43. Bacot S., Bernoud-Hubac N., Chantegrel B., Deshayes C., Doutheau A., Ponsin G., Lagarde M., Guichardant M. Evidence for in situ ethanolamine phospholipid adducts with hydroxy-alkenals. J. Lipid Res. 2007, 48:816-825.
44. Winter C.K., Segall H.J., Haddon W.F. Formation of cyclic adducts of deoxyguanosine with the aldehydes trans-4-hydroxy-2-hexenal and trans-4-hydroxy-2-nonenal in vitro. Cancer Res. 1986, 46:5682-5686.
45. Yamada S., Funada T., Shibata N., Kobayashi M., Kawai Y., Tatsuda E., Furuhata A., Uchida K. Protein-bound 4-hydroxy-2-hexenal as a marker of oxidized n-3 polyunsaturated fatty acids. J. Lipid Res. 2004, 45:626-634.
46. Grasse L.D., Lame M.W., Segall H.J. In vivo covalent binding of trans-4-hydroxy-2-hexenal to rat liver macromolecules. Toxicol. Lett. 1985, 29:43-49.
47. Brambilla G., Sciaba L., Faggin P., Maura A., Marinari U.M., Ferro M., Esterbauer H. Cytotoxicity, DNA fragmentation and sister-chromatid exchange in chinese hamster ovary cells exposed to the lipid peroxidation product 4-hydroxynonenal and homologous aldehydes. Mutat. Res. 1986, 171:169-176.
48. Eckl P.M., Ortner A., Esterbauer H. Genotoxic properties of 4-hydroxyalkenals and analogous aldehydes. Mutat. Res. 1993, 290:183-192.
49. Guichardant M., Taibi-Tronche P., Fay L.B., Lagarde M. Covalent modifications of aminophospholipids by 4-hydroxynonenal. Free Radic. Biol. Med. 1998, 25:1049-1056.
50. Tanito M., Brush R.S., Elliott M.H., Wicker L.D., Henry K.R., Anderson R.E. High levels of retinal membrane docosahexaenoic acid increase susceptibility to stress-induced degeneration. J. Lipid Res. 2009, 50:807-819.
51. Tanito M., Li F., Elliott M.H., Dittmar M., Anderson R.E. Protective effect of tempol derivatives against light-induced retinal damage in rats. Invest. Ophthalmol. Vis. Sci. 2007, 48:1900-1905.
52. Furukawa F., Nishikawa A., Kasahara K., Miyauchi M., Nakamura H., Son H.Y., Uchida K., Hirose M. Involvement of lipid peroxidation in spontaneous pancreatitis in wbn/kob rats. Pancreas 2001, 22:427-430.
53. Kapphahn R.J., Giwa B.M., Berg K.M., Roehrich H., Feng X., Olsen T.W., Ferrington D.A. Retinal proteins modified by 4-hydroxynonenal: Identification of molecular targets. Exp. Eye Res. 2006, 83:165-175.
54. Reed T.T., Pierce W.M., Markesbery W.R., Butterfield D.A. Proteomic identification of hne-bound proteins in early alzheimer disease: Insights into the role of lipid peroxidation in the progression of ad. Brain Res. 2009, 1274:66-76.
55. Reed T., Perluigi M., Sultana R., Pierce W.M., Klein J.B., Turner D.M., Coccia R., Markesbery W.R., Butterfield D.A. Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: Insight into the role of lipid peroxidation in the progression and pathogenesis of alzheimer's disease. Neurobiol. Dis. 2008, 30:107-120.
56. Vila A., Tallman K.A., Jacobs A.T., Liebler D.C., Porter N.A., Marnett L.J. Identification of protein targets of 4-hydroxynonenal using click chemistry for ex vivo biotinylation of azido and alkynyl derivatives. Chem. Res. Toxicol. 2008, 21:432-444.
57. Tanito M., Haniu H., Elliott M.H., Singh A.K., Matsumoto H., Anderson R.E. Identification of 4-hydroxynonenal-modified retinal proteins induced by photooxidative stress prior to retinal degeneration. Free Radic. Biol. Med. 2006, 41:1847-1859.
58. Perluigi M., Fai Poon H., Hensley K., Pierce W.M., Klein J.B., Calabrese V., De Marco C., Butterfield D.A. Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in g93a-sod1 transgenic mice-a model of familial amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2005, 38:960-968.
59. Carbone D.L., Doorn J.A., Kiebler Z., Ickes B.R., Petersen D.R. Modification of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic alcoholic liver disease. J. Pharmacol. Exp. Ther. 2005, 315:8-15.
60. Carbone D.L., Doorn J.A., Kiebler Z., Petersen D.R. Cysteine modification by lipid peroxidation products inhibits protein disulfide isomerase. Chem. Res. Toxicol. 2005, 18:1324-1331.
61. Grimsrud P.A., Picklo M.J., Griffin T.J., Bernlohr D.A. Carbonylation of adipose proteins in obesity and insulin resistance: Identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal. Mol. Cell. Proteomics 2007, 6:624-637.
62. Lee J.Y., Je J.H., Kim D.H., Chung S.W., Zou Y., Kim N.D., Ae Yoo M., Suck Baik H., Yu B.P., Chung H.Y. Induction of endothelial apoptosis by 4-hydroxyhexenal. Eur. J. Biochem. 2004, 271:1339-1347.
63. Lee Y.S., Wander R.C. Reduced effect on apoptosis of 4-hydroxyhexenal and oxidized ldl enriched with n-3 fatty acids from postmenopausal women. J. Nutr. Biochem. 2005, 16:213-221.
64. Choudhary S., Xiao T., Srivastava S., Zhang W., Chan L.L., Vergara L.A., Van Kuijk F.J., Ansari N.H. Toxicity and detoxification of lipid-derived aldehydes in cultured retinal pigmented epithelial cells. Toxicol. Appl. Pharmacol. 2005, 204:122-134.
65. Choudhary S., Zhang W., Zhou F., Campbell G.A., Chan L.L., Thompson E.B., Ansari N.H. Cellular lipid peroxidation end-products induce apoptosis in human lens epithelial cells. Free Radic. Biol. Med. 2002, 32:360-369.
66. Kristal B.S., Park B.K., Yu B.P. 4-hydroxyhexenal is a potent inducer of the mitochondrial permeability transition. J. Biol. Chem. 1996, 271:6033-6038.
67. Kristal B.S., Dubinsky J.M. Mitochondrial permeability transition in the central nervous system: Induction by calcium cycling-dependent and -independent pathways. J. Neurochem. 1997, 69:524-538.
68. Awasthi Y.C., Sharma R., Sharma A., Yadav S., Singhal S.S., Chaudhary P., Awasthi S. Self-regulatory role of 4-hydroxynonenal in signaling for stress-induced programmed cell death. Free Radic. Biol. Med. 2008, 45:111-118.
69. Chen Z.H., Saito Y., Yoshida Y., Sekine A., Noguchi N., Niki E. 4-hydroxynonenal induces adaptive response and enhances pc12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of nrf2. J. Biol. Chem. 2005, 280:41921-41927.
70. Chiarpotto E., Domenicotti C., Paola D., Vitali A., Nitti M., Pronzato M.A., Biasi F., Cottalasso D., Marinari U.M., Dragonetti A., Cesaro P., Isidoro C., Poli G. Regulation of rat hepatocyte protein kinase c beta isoenzymes by the lipid peroxidation product 4-hydroxy-2, 3-nonenal: A signaling pathway to modulate vesicular transport of glycoproteins. Hepatology 1999, 29:1565-1572.
71. Kumagai T., Matsukawa N., Kaneko Y., Kusumi Y., Mitsumata M., Uchida K. A lipid peroxidation-derived inflammatory mediator: Identification of 4-hydroxy-2-nonenal as a potential inducer of cyclooxygenase-2 in macrophages. J. Biol. Chem. 2004, 279:48389-48396.
72. Levy S., Jaiswal A.K., Forman H.J. The role of c-jun phosphorylation in epre activation of phase ii genes. Free Radic. Biol. Med. 2009, 47:1172-1179.
73. Nitti M., Domenicotti C., d'Abramo C., Assereto S., Cottalasso D., Melloni E., Poli G., Biasi F., Marinari U.M., Pronzato M.A. Activation of pkc-beta isoforms mediates hne-induced mcp-1 release by macrophages. Biochem. Biophys. Res. Commun. 2002, 294:547-552.
74. Wagner T.M., Mullally J.E., Fitzpatrick F.A. Reactive lipid species from cyclooxygenase-2 inactivate tumor suppressor lkb1/stk11: Cyclopentenone prostaglandins and 4-hydroxy-2-nonenal covalently modify and inhibit the amp-kinase kinase that modulates cellular energy homeostasis and protein translation. J. Biol. Chem. 2006, 281:2598-2604.
75. Zarrouki B., Soares A.F., Guichardant M., Lagarde M., Geloen A. The lipid peroxidation end-product 4-hne induces cox-2 expression through p38mapk activation in 3t3-l1 adipose cell. FEBS Lett. 2007, 581:2394-2400.
76. Zhang H., Liu H., Dickinson D.A., Liu R.M., Postlethwait E.M., Laperche Y., Forman H.J. Gamma-glutamyl transpeptidase is induced by 4-hydroxynonenal via epre/nrf2 signaling in rat epithelial type ii cells. Free Radic. Biol. Med. 2006, 40:1281-1292.
77. Zhang H., Liu H., Iles K.E., Liu R.M., Postlethwait E.M., Laperche Y., Forman H.J. 4-hydroxynonenal induces rat gamma-glutamyl transpeptidase through mitogen-activated protein kinase-mediated electrophile response element/nuclear factor erythroid 2-related factor 2 signaling. Am. J. Respir. Cell Mol. Biol. 2006, 34:174-181.
78. Je J.H., Lee J.Y., Jung K.J., Sung B., Go E.K., Yu B.P., Chung H.Y. Nf-kappab activation mechanism of 4-hydroxyhexenal via nik/ikk and p38 mapk pathway. FEBS Lett. 2004, 566:183-189.
79. Lee J.Y., Je J.H., Jung K.J., Yu B.P., Chung H.Y. Induction of endothelial inos by 4-hydroxyhexenal through nf-kappab activation. Free Radic. Biol. Med. 2004, 37:539-548.
80. Ishii T., Itoh K., Ruiz E., Leake D.S., Unoki H., Yamamoto M., Mann G.E. Role of nrf2 in the regulation of cd36 and stress protein expression in murine macrophages: Activation by oxidatively modified ldl and 4-hydroxynonenal. Circ. Res. 2004, 94:609-616.
81. Levonen A.L., Landar A., Ramachandran A., Ceaser E.K., Dickinson D.A., Zanoni G., Morrow J.D., Darley-Usmar V.M. Cellular mechanisms of redox cell signalling: Role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem. J. 2004, 378:373-382.
82. Ceaser E.K., Ramachandran A., Levonen A.L., Darley-Usmar V.M. Oxidized low-density lipoprotein and 15-deoxy-delta 12, 14-pgj2 increase mitochondrial complex i activity in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H2298-H2308.
83. Yamamoto N., Sawada H., Izumi Y., Kume T., Katsuki H., Shimohama S., Akaike A. Proteasome inhibition induces glutathione synthesis and protects cells from oxidative stress: Relevance to parkinson disease. J. Biol. Chem. 2007, 282:4364-4372.
84. Kobayashi A., Kang M.I., Watai Y., Tong K.I., Shibata T., Uchida K., Yamamoto M. Oxidative and electrophilic stresses activate nrf2 through inhibition of ubiquitination activity of keap1. Mol. Cell. Biol. 2006, 26:221-229.
85. Kaspar J.W., Niture S.K., Jaiswal A.K. Nrf2:Inrf2 (keap1) signaling in oxidative stress. Free Radic. Biol. Med. 2009, 47:1304-1309.
86. Jaiswal A.K. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic. Biol. Med. 2004, 36:1199-1207.
87. Nguyen T., Nioi P., Pickett C.B. The nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J. Biol. Chem. 2009, 284:13291-13295.
88. Nguyen T., Yang C.S., Pickett C.B. The pathways and molecular mechanisms regulating nrf2 activation in response to chemical stress. Free Radic. Biol. Med. 2004, 37:433-441.
89. Dasuri K., Nguyen A., Zhang L., Fernandez-Kim O.S., Bruce-Keller A.J., Blalock B.A., Cabo R.D., Keller J.N. Comparison of rat liver and brain proteasomes for oxidative stress-induced inactivation: Influence of ageing and dietary restriction. Free Radic. Res. 2009, 43:28-36.
90. Bardag-Gorce F., Li J., French B.A., French S.W. The effect of ethanol-induced cyp2e1 on proteasome activity: The role of 4-hydroxynonenal. Exp. Mol. Pathol. 2005, 78:109-115.
91. Ferrington D.A., Kapphahn R.J. Catalytic site-specific inhibition of the 20s proteasome by 4-hydroxynonenal. FEBS Lett. 2004, 578:217-223.
92. Rossi M.A., Fidale F., Garramone A., Esterbauer H., Dianzani M.U. Effect of 4-hydroxylalkenals on hepatic phosphatidylinositol-4, 5-bisphosphate-phospholipase c. Biochem. Pharmacol. 1990, 39:1715-1719.
93. Murphy T.C., Poppe C., Porter J.E., Montine T.J., Picklo M.J. 4-hydroxy-trans-2-nonenoic acid is a gamma-hydroxybutyrate receptor ligand in the cerebral cortex and hippocampus. J. Neurochem. 2004, 89:1462-1470.
94. Ramana K.V., Bhatnagar A., Srivastava S., Yadav U.C., Awasthi S., Awasthi Y.C., Srivastava S.K. Mitogenic responses of vascular smooth muscle cells to lipid peroxidation-derived aldehyde 4-hydroxy-trans-2-nonenal (hne): Role of aldose reductase-catalyzed reduction of the hne-glutathione conjugates in regulating cell growth. J. Biol. Chem. 2006, 281:17652-17660.
95. Spite M., Summers L., Porter T.F., Srivastava S., Bhatnagar A., Serhan C.N. Resolvin d1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress. Br. J. Pharmacol. 2009, 158:1062-1073.
96. Brown, G. C.; Neher, J. J. Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol. Neurobiol. in press.
97. Lue, L. F.; Kuo, Y. M.; Beach, T.; Walker, D. G. Microglia activation and antiinflammatory regulation in alzheimer's disease. Mol. Neurobiol. in press.
98. Chaiyasit W., Elias R.J., McClements D.J., Decker E.A. Role of physical structures in bulk oils on lipid oxidation. Crit. Rev. Food Sci. Nutr. 2007, 47:299-317.
99. Frankel E.N., Satue-Gracia T., Meyer A.S., German J.B. Oxidative stability of fish and algae oils containing long-chain polyunsaturated fatty acids in bulk and in oil-in-water emulsions. J. Agric. Food Chem. 2002, 50:2094-2099.
100. Munasinghe D.M., Kawahara S., Sakai T. Effects of nacl on 4-hydroxy-2-hexenal formation in yellowtail meat stored at 0 degrees c. Biosci. Biotechnol. Biochem. 2006, 70:3036-3038.
101. Calzada C., Colas R., Guillot N., Guichardant M., Laville M., Vericel E., Lagarde M. Subgram daily supplementation with docosahexaenoic acid protects low-density lipoproteins from oxidation in healthy men. Atherosclerosis 2010, 208:467-472.
102. Michalski M.C., Calzada C., Makino A., Michaud S., Guichardant M. Oxidation products of polyunsaturated fatty acids in infant formulas compared to human milk-a preliminary study. Mol. Nutr. Food Res. 2008, 52:1478-1485.
103. Surh J., Lee S., Kwon H. 4-hydroxy-2-alkenals in polyunsaturated fatty acids-fortified infant formulas and other commercial food products. Food Addit. Contam. 2007, 24:1209-1218.
104. Kasai H., Kawai K. 4-oxo-2-hexenal, a mutagen formed by omega-3 fat peroxidation: Occurrence, detection and adduct formation. Mutat. Res. 2008, 659:56-59.
105. Kasai H., Maekawa M., Kawai K., Hachisuka K., Takahashi Y., Nakamura H., Sawa R., Matsui S., Matsuda T. 4-oxo-2-hexenal, a mutagen formed by omega-3 fat peroxidation, causes DNA adduct formation in mouse organs. Ind. Health 2005, 43:699-701.
106. Kawai K., Matsuno K., Kasai H. Detection of 4-oxo-2-hexenal, a novel mutagenic product of lipid peroxidation, in human diet and cooking vapor. Mutat. Res. 2006, 603:186-192.
107. Innocenzi P.J., Hall D., Cross J.V., Hesketh H. Attraction of male european tarnished plant bug, lygus rugulipennis to components of the female sex pheromone in the field. J. Chem. Ecol. 2005, 31:1401-1413.
108. Innocenzi P.J., Hall D.R., Cross J.V., Masuh H., Phythian S.J., Chittamaru S., Guarino S. Investigation of long-range female sex pheromone of the european tarnished plant bug, lygus rugulipennis: Chemical, electrophysiological, and field studies. J. Chem. Ecol. 2004, 30:1509-1529.
109. Williams L., Evans P.E., Bowers W.S. Defensive chemistry of an aposematic bug, pachycoris stallii uhler and volatile compounds of its host plant croton californicus muell.-arg. J. Chem. Ecol. 2001, 27:203-216.
110. Byers J.A. Production and predator-induced release of volatile chemicals by the plant bug lygus hesperus. J. Chem. Ecol. 2006, 32:2205-2218.
111. Lin D., Lee H.G., Liu Q., Perry G., Smith M.A., Sayre L.M. 4-oxo-2-nonenal is both more neurotoxic and more protein reactive than 4-hydroxy-2-nonenal. Chem. Res. Toxicol. 2005, 18:1219-1231.
112. Maekawa M., Kawai K., Takahashi Y., Nakamura H., Watanabe T., Sawa R., Hachisuka K., Kasai H. Identification of 4-oxo-2-hexenal and other direct mutagens formed in model lipid peroxidation reactions as dguo adducts. Chem. Res. Toxicol. 2006, 19:130-138.
113. Shibata T., Iio K., Kawai Y., Shibata N., Kawaguchi M., Toi S., Kobayashi M., Kobayashi M., Yamamoto K., Uchida K. Identification of a lipid peroxidation product as a potential trigger of the p53 pathway. J. Biol. Chem. 2006, 281:1196-1204.
114. Jian W., Lee S.H., Mesaros C., Oe T., Elipe M.V., Blair I.A. A novel 4-oxo-2(e)-nonenal-derived endogenous thiadiazabicyclo glutathione adduct formed during cellular oxidative stress. Chem. Res. Toxicol. 2007, 20:1008-1018.